NOTCH2產(chǎn)品信息
英文名稱:Neurogenic locus notch homolog protein 2
中文名稱:神經(jīng)源性基因座notch同源蛋白-2
靶點(diǎn)別稱:NOTCH2
物種:Human
標(biāo)簽:Fc Tag
屬性:Protein
標(biāo)記:Unconjugated
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human NOTCH2, Fc Tag (NO2-H5255) is expressed from human 293 cells (HEK293). It contains AA Leu 26 - Gln 530 (Accession # Q04721-1).
Predicted N-terminus: Leu 26
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a human IgG1 Fc tag at the C-terminus.
The protein has a calculated MW of 80.5 kDa. The protein migrates as 90 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
作為膜結(jié)合配體Jagged-1(JAG1)、Jagged-2(JAG2)和Delta-1(DLL1)的受體,調(diào)節(jié)細(xì)胞命運(yùn)的決定。當(dāng)配體通過釋放的缺口細(xì)胞內(nèi)結(jié)構(gòu)域(NICD)激活時,它與RBPJ/RBPSHH形成轉(zhuǎn)錄激活物復(fù)合物,并激活分裂位點(diǎn)增強(qiáng)子的基因。影響分化、增殖和凋亡程序的實施(按相似性)。參與骨重塑和穩(wěn)態(tài)。與RELA/p65合作,增強(qiáng)NFATc1啟動子活性,并積極調(diào)節(jié)RANKL誘導(dǎo)的破骨細(xì)胞分化。積極調(diào)節(jié)癌癥細(xì)胞的自我更新。
關(guān)鍵字: NOTCH2;NOTCH2蛋白;NOTCH2重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。